Maryland, 17 Feb 2023: The U.S. Food and Drug Administration has approved Apellis Pharmaceuticals Inc's drug to treat an advanced eye disorder that is one of the leading causes of blindness globally, the company said on Friday.

 

The drug, which would be sold......
View Details

Related News

• Gujarat FDCA attributes 45% of drug samples failing quality tests due to dissolution testing (25-09-2023)

---

• CDSCO says samples labelled as Cipla's and Sun Pharma's drugs failed in July could be spurious (25-09-2023)

---

• Govt in process of identifying additional regulatory interventions to stop Misuse of Antimicrobials (25-09-2023)

---

• Resistance to last-resort antibiotics Carbapenem growing in India: ICMR report (25-09-2023)

---

• 4 arrested with 375 bottles of Eskuf cough syrup worth Rs 4 lakh (25-09-2023)

---

• Ghaziabad: Fake Augmentin 625 Duo and Ultracet worth Rs 8 lakh seized, four arrested (24-09-2023)

---

• Police recovered 292 intoxicating capsules and 5760 pills in Ambala (24-09-2023)

---

• One Arrested by Cachar Police with 18,000 Yaba Tablets (24-09-2023)

---

• Indian-origin girl receives first rejection-free kidney from mother in UK (24-09-2023)

---

• 3D-printed medical devices gain ground (24-09-2023)

---